Baby Safety / Compounds / Tetramethrin

Is Tetramethrin safe for babies and kids?

Context-dependent for kids

(Babies-specific data is limited; this page draws from human pregnant context.) Pregnancy alters the metabolism and distribution of Tetramethrin, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

What is tetramethrin?

The IUPAC name is (1,3-dioxo-4,5,6,7-tetrahydroisoindol-2-yl)methyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate.

Also known as: (1,3-dioxo-4,5,6,7-tetrahydroisoindol-2-yl)methyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate, Phthalthrin, Neo-pynamin, Bioneopynamin.

IUPAC name
(1,3-dioxo-4,5,6,7-tetrahydroisoindol-2-yl)methyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate
CAS number
7696-12-0
Molecular formula
C19H25NO4
Molecular weight
331.4 g/mol
SMILES
CC(=CC1C(C1(C)C)C(=O)OCN2C(=O)C3=C(C2=O)CCCC3)C
PubChem CID
83975

Risk for babies

Context-dependent

Pregnancy alters the metabolism and distribution of Tetramethrin, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Risk for pregnant and nursing people

Context-dependent

Pregnancy alters the metabolism and distribution of Tetramethrin, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

1 regulatory bodyhas classified Tetramethrin.

AgencyYearClassificationNotes
EPA CTX / EPA OPPGroup C Possible Human Carcinogen

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter tetramethrin

  • Industrial FacilitiesManufacturing plants, Chemical storage areas, Waste treatment sites
  • Occupational EnvironmentsFactories, Warehouses, Transportation vehicles

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Tetramethrin:

  • Physical/mechanical pest control (IPM)
    Trade-offs: More labor-intensive. May not be sufficient for severe infestations.
    Relative cost: 1.2-2×

Frequently asked questions

What products contain tetramethrin?

Tetramethrin appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).

See Tetramethrin in the baby app

Look up products containing tetramethrin, compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (2)

  1. US EPA Pyrethroid Reregistration Eligibility Decision — cypermethrin/deltamethrin/lambda-cyhalothrin/bifenthrin/cyfluthrin/fenvalerate/tau-fluvalinate/fenpropathrin; type I/II classification; aquatic toxicity; cat sensitivity; sodium channel mechanism; human paresthesia; buffer zones (2011) (2011) — regulatory
  2. ASPCA Animal Poison Control Center: Pyrethroid Toxicosis in Cats and Dogs — type I vs type II CS/T syndromes; extreme cat sensitivity (sodium channel/UGT deficiency); bathing decontamination; methocarbamol tremor control; cyproheptadine; lipid emulsion severe cases (2023) (2023) — veterinary

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →